sur Moderna, Inc. (NASDAQ:MRNA)
Moderna to Present at Barclays Science Call Series
Cambridge-based Moderna, Inc. will participate in the upcoming Barclays Speaking the Science Call Series. The event is scheduled for June 16, 2025, at 10:00am ET. Investors may access a live webcast of the presentation via the Moderna website under the "Events and Presentations" section.
The webcast will be archived on Moderna's website for at least 30 days post-presentation, allowing interested parties flexibility in viewing. This event provides Moderna an opportunity to engage with investors and discuss developments in mRNA technology and their applications.
Moderna, known for its mRNA platform, continues to advance its therapeutic solutions across various medical fields, including infectious diseases and immuno-oncology.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Moderna, Inc.